Molecular machine learning (ML) underpins critical workflows in drug discovery, material science, and catalyst optimization by rapidly predicting molecular interactions and properties. For ...

This secret geometry of wave functions went undetected for decades. But when quantum materials began to surprise physicists with inexplicable behaviors, physicists in the 1980s realized that some of ...

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

Scientists have unlocked new details on important receptor proteins—promising targets for the creation of novel drugs for ...

With this final piece in place, the geometry of convex bodies in high dimensions is now a little less mysterious—although, as always in mathematics, each new slice reveals more questions to explore.

Lecanemab has also been filed via this route with the FDA, with a decision due by 6 January. Clarity AD's primary endpoint is the Clinical Dementia Rating-Sum of Boxes (CDR-SB) ...

In their recent paper, the Amsterdam-Nijmegen research team led by Prof. Wybren Jan Buma of Molecular Photonics present a successful approach to determining the precise molecular geometry of ...

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease.

Experts said that drugs, such as such as lecanemab and donanemab, that target amyloid protein build-up in the brain - a key characteristic of both diseases - are “only one part of the overall ...